News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
655,885 Results
Type
Article (34445)
Company Profile (640)
Press Release (620800)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (199183)
Career Advice (2137)
Deals (36206)
Drug Delivery (102)
Drug Development (78192)
Employer Resources (163)
FDA (15214)
Job Trends (14738)
News (334589)
Policy (28767)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (6)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (1551)
Academic (1)
Accelerated approval (5)
Adcomms (13)
Allergies (83)
Alliances (48050)
ALS (92)
Alzheimer's disease (1326)
Antibody-drug conjugate (ADC) (127)
Approvals (15201)
Artificial intelligence (246)
Autoimmune disease (27)
Automation (13)
Bankruptcy (375)
Best Places to Work (10945)
BIOSECURE Act (21)
Biosimilars (97)
Biotechnology (437)
Bladder cancer (61)
Brain cancer (25)
Breast cancer (238)
Cancer (1985)
Cardiovascular disease (163)
Career advice (1767)
Career pathing (31)
CAR-T (143)
Cell therapy (410)
Cervical cancer (17)
Clinical research (63856)
Collaboration (827)
Compensation (508)
Complete response letters (27)
COVID-19 (2212)
CRISPR (41)
C-suite (242)
Cystic fibrosis (98)
Data (1987)
Decentralized trials (2)
Denatured (4)
Depression (46)
Diabetes (242)
Diagnostics (6350)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (37)
Drug discovery (121)
Drug pricing (98)
Drug shortages (24)
Duchenne muscular dystrophy (87)
Earnings (83043)
Editorial (37)
Employer branding (24)
Employer resources (139)
Events (110006)
Executive appointments (714)
FDA (16326)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (731)
Gene editing (107)
Generative AI (24)
Gene therapy (294)
GLP-1 (717)
Government (2919)
Grass and pollen (5)
Guidances (45)
Healthcare (16348)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (123)
Indications (26)
Infectious disease (2348)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (91)
Interviews (425)
IPO (17199)
IRA (41)
Job creations (4235)
Job search strategy (1472)
Kidney cancer (9)
Labor market (34)
Layoffs (531)
Leadership (17)
Legal (7151)
Liver cancer (67)
Lung cancer (282)
Lymphoma (125)
Machine learning (3)
Management (58)
Manufacturing (305)
MASH (62)
Medical device (13492)
Medtech (13497)
Mergers & acquisitions (19526)
Metabolic disorders (649)
Multiple sclerosis (77)
NASH (18)
Neurodegenerative disease (93)
Neuropsychiatric disorders (28)
Neuroscience (1849)
NextGen: Class of 2025 (6074)
Non-profit (2351)
Northern California (2547)
Now hiring (39)
Obesity (355)
Opinion (249)
Ovarian cancer (70)
Pain (86)
Pancreatic cancer (81)
Parkinson's disease (145)
Partnered (19)
Patents (226)
Patient recruitment (98)
Peanut (48)
People (57270)
Pharmaceutical (132)
Pharmacy benefit managers (16)
Phase I (20144)
Phase II (28534)
Phase III (21076)
Pipeline (1125)
Policy (131)
Postmarket research (1928)
Preclinical (8202)
Press Release (70)
Prostate cancer (94)
Psychedelics (35)
Radiopharmaceuticals (258)
Rare diseases (371)
Real estate (5790)
Recruiting (64)
Regulatory (20555)
Reports (35)
Research institute (1731)
Resumes & cover letters (330)
Rett syndrome (3)
RNA editing (4)
RSV (43)
Schizophrenia (73)
Series A (132)
Series B (87)
Service/supplier (26)
Sickle cell disease (53)
Southern California (2150)
Special edition (16)
Spinal muscular atrophy (149)
Sponsored (22)
Startups (3883)
State (2)
Stomach cancer (12)
Supply chain (67)
Tariffs (26)
The Weekly (48)
United States (22162)
Vaccines (641)
Venture capitalists (41)
Weight loss (240)
Women's health (24)
Worklife (18)
Date
Today (31)
Last 7 days (482)
Last 30 days (2391)
Last 365 days (33397)
2025 (9338)
2024 (35833)
2023 (40580)
2022 (50863)
2021 (54118)
2020 (51248)
2019 (42625)
2018 (32504)
2017 (32768)
2016 (31123)
2015 (36584)
2014 (29197)
2013 (24143)
2012 (25762)
2011 (26043)
2010 (23780)
Location
Africa (692)
Alabama (58)
Alaska (7)
Arizona (162)
Arkansas (11)
Asia (40316)
Australia (6605)
California (5874)
Canada (1944)
China (500)
Colorado (256)
Connecticut (274)
Delaware (129)
Europe (88125)
Florida (822)
Georgia (204)
Hawaii (1)
Idaho (55)
Illinois (450)
India (28)
Indiana (311)
Iowa (10)
Japan (144)
Kansas (99)
Kentucky (23)
Louisiana (11)
Maine (66)
Maryland (741)
Massachusetts (4557)
Michigan (230)
Minnesota (382)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (22)
Nevada (55)
New Hampshire (65)
New Jersey (1688)
New Mexico (30)
New York (1651)
North Carolina (1031)
North Dakota (6)
Northern California (2547)
Ohio (183)
Oklahoma (11)
Oregon (41)
Pennsylvania (1304)
Puerto Rico (11)
Rhode Island (33)
South America (1078)
South Carolina (20)
South Dakota (1)
Southern California (2150)
Tennessee (82)
Texas (856)
Utah (170)
Virginia (145)
Washington D.C. (57)
Washington State (553)
West Virginia (3)
Wisconsin (47)
655,885 Results for "eurofins discoverx a eurofins discovery company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration
October 10, 2024
·
2 min read
Eurofins CDMO Alphora Inc. Announces the Launch of Expanded Drug Product Analytical Laboratory
Eurofins CDMO Alphora Inc., a global Contract Development & Manufacturing Organization and part of the international network of Eurofins laboratories, is pleased to announce a significant expansion of its Drug Product Analytical Services Laboratory, increasing its footprint three-fold.
May 29, 2024
·
2 min read
Press Releases
Awakn Selects Eurofins Discovery for Pharmacology Testing in New Chemical Entity (NCE) Pre-Clinical Program
October 4, 2024
·
5 min read
Eurofins DiscoverX Celebrates Shanghai Office Opening
Eurofins DiscoverX announced the official opening of its new China biotechnology office in Shanghai.
June 29, 2022
·
2 min read
Press Releases
Eurofins Genomics US Expands Capabilities with New GMP Oligonucleotide Manufacturing Facility
September 20, 2024
·
2 min read
Business
Eurofins Genomics Opens New Seattle Laboratory for Express Oxford Nanopore Sequencing
Eurofins Genomics, a global leader in sequencing services, announces the opening of a new, certified sequencing lab in Bothell, Washington, serving the greater Seattle area.
January 24, 2024
·
2 min read
Press Releases
Eurofins CDMO Alphora Inc. Announces Construction of GMP Biologics Manufacturing Facility
September 25, 2024
·
2 min read
Business
Eurofins Discovery Collaborating with Invasight on Cancer Therapies
Eurofins Discovery, the leading provider of products and services to the drug discovery industry, announced its collaboration with Invasight, a Switzerland-based biotech developing cancer therapies.
February 14, 2023
·
2 min read
Eurofins CDMO Alphora Inc. Announces the Completion of a New Pilot Scale Biologics Development Facility
Eurofins CDMO Alphora Inc., a Contract Drug and Manufacturing Organization based in Mississauga, Canada, is excited to announce the successful completion of its pilot-scale biologics development facility.
January 17, 2024
·
2 min read
Bio NC
KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program
Eurofins DiscoverX Products, LLC (Eurofins DiscoverX), an industry leader in assays for drug discovery, development, and QC lot release, announced today the expansion of its Bioassay Certification Program through its certification of KBI Biopharma, Inc. (KBI), a JSR Life Sciences company.
October 11, 2021
·
4 min read
1 of 65,589
Next
